Form 8-K - Current report:
SEC Accession No. 0001193125-25-004057
Filing Date
2025-01-10
Accepted
2025-01-10 06:56:30
Documents
59
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d909941d8k.htm   iXBRL 8-K 53859
2 EX-99.1 d909941dex991.htm EX-99.1 39853
3 EX-99.2 d909941dex992.htm EX-99.2 48139
7 GRAPHIC g909941ex99_2p10g1.jpg GRAPHIC 340858
8 GRAPHIC g909941ex99_2p11g1.jpg GRAPHIC 229154
9 GRAPHIC g909941ex99_2p12g1.jpg GRAPHIC 274682
10 GRAPHIC g909941ex99_2p13g1.jpg GRAPHIC 325615
11 GRAPHIC g909941ex99_2p14g1.jpg GRAPHIC 295750
12 GRAPHIC g909941ex99_2p15g1.jpg GRAPHIC 265968
13 GRAPHIC g909941ex99_2p16g1.jpg GRAPHIC 273361
14 GRAPHIC g909941ex99_2p17g1.jpg GRAPHIC 168521
15 GRAPHIC g909941ex99_2p18g1.jpg GRAPHIC 192497
16 GRAPHIC g909941ex99_2p19g1.jpg GRAPHIC 185541
17 GRAPHIC g909941ex99_2p1g1.jpg GRAPHIC 306163
18 GRAPHIC g909941ex99_2p20g1.jpg GRAPHIC 267739
19 GRAPHIC g909941ex99_2p21g1.jpg GRAPHIC 219930
20 GRAPHIC g909941ex99_2p22g1.jpg GRAPHIC 251147
21 GRAPHIC g909941ex99_2p23g1.jpg GRAPHIC 252703
22 GRAPHIC g909941ex99_2p24g1.jpg GRAPHIC 325333
23 GRAPHIC g909941ex99_2p25g1.jpg GRAPHIC 217781
24 GRAPHIC g909941ex99_2p26g1.jpg GRAPHIC 238364
25 GRAPHIC g909941ex99_2p27g1.jpg GRAPHIC 400166
26 GRAPHIC g909941ex99_2p28g1.jpg GRAPHIC 321678
27 GRAPHIC g909941ex99_2p29g1.jpg GRAPHIC 341081
28 GRAPHIC g909941ex99_2p2g1.jpg GRAPHIC 778544
29 GRAPHIC g909941ex99_2p30g1.jpg GRAPHIC 268957
30 GRAPHIC g909941ex99_2p31g1.jpg GRAPHIC 260977
31 GRAPHIC g909941ex99_2p32g1.jpg GRAPHIC 251729
32 GRAPHIC g909941ex99_2p33g1.jpg GRAPHIC 148370
33 GRAPHIC g909941ex99_2p34g1.jpg GRAPHIC 259049
34 GRAPHIC g909941ex99_2p35g1.jpg GRAPHIC 182008
35 GRAPHIC g909941ex99_2p36g1.jpg GRAPHIC 185686
36 GRAPHIC g909941ex99_2p37g1.jpg GRAPHIC 216495
37 GRAPHIC g909941ex99_2p38g1.jpg GRAPHIC 300516
38 GRAPHIC g909941ex99_2p39g1.jpg GRAPHIC 261609
39 GRAPHIC g909941ex99_2p3g1.jpg GRAPHIC 148477
40 GRAPHIC g909941ex99_2p40g1.jpg GRAPHIC 234858
41 GRAPHIC g909941ex99_2p41g1.jpg GRAPHIC 323615
42 GRAPHIC g909941ex99_2p42g1.jpg GRAPHIC 193204
43 GRAPHIC g909941ex99_2p43g1.jpg GRAPHIC 302206
44 GRAPHIC g909941ex99_2p4g1.jpg GRAPHIC 355176
45 GRAPHIC g909941ex99_2p5g1.jpg GRAPHIC 219646
46 GRAPHIC g909941ex99_2p6g1.jpg GRAPHIC 257065
47 GRAPHIC g909941ex99_2p7g1.jpg GRAPHIC 149689
48 GRAPHIC g909941ex99_2p8g1.jpg GRAPHIC 390887
49 GRAPHIC g909941ex99_2p9g1.jpg GRAPHIC 299733
50 GRAPHIC g909941g0110031139939.jpg GRAPHIC 2973
  Complete submission text file 0001193125-25-004057.txt   16393390

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyn-20250110.xsd EX-101.SCH 2847
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20250110_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20250110_pre.xml EX-101.PRE 10811
61 EXTRACTED XBRL INSTANCE DOCUMENT d909941d8k_htm.xml XML 3497
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 25520322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)